
Okyo Pharma (NASDAQ: OKYO)
$2.67
(-2.9%)
-$0.08
Price as of July 16, 2025, 9:52 a.m. ET
Okyo Pharma Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Okyo Pharma Company Info
OKYO Pharma Ltd operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It targets to cure and prevent the following conditions: dry eye disease, non-infectious anterior uveitis, allergic conjunctivitis, and ocular pain. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.